|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Total cash | ||||||||||||||||||||
| Real estate inventory: | ||||||||||||||||||||
| Owned inventory | ||||||||||||||||||||
| Consolidated real estate not owned | ||||||||||||||||||||
| Total real estate inventory | ||||||||||||||||||||
| Land deposits | ||||||||||||||||||||
| Mortgage loans held for sale | ||||||||||||||||||||
| Lease right of use assets | ||||||||||||||||||||
| Prepaid expenses and other assets, net | ||||||||||||||||||||
| Other receivables, net | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets of consolidated joint ventures | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Estimated development liabilities | ||||||||||||||||||||
| Senior notes, net | ||||||||||||||||||||
| Loans payable and other borrowings | ||||||||||||||||||||
| Revolving credit facility borrowings | ||||||||||||||||||||
| Mortgage warehouse facilities borrowings | ||||||||||||||||||||
| Liabilities attributable to consolidated real estate not owned | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, $0.00001 par value, 400,000,000 shares authorized, 162,809,286 and 162,061,709 shares issued, 96,536,827 and 102,241,978 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost, 66,272,459 and 59,819,731 shares as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders’ equity attributable to TMHC | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and owners’ equity | ||||||||||||||||||||
Loading...
